Evidence map›Paper›PMID 31671144›Full record

ArticlePloS one2019

Deep-learning-based risk stratification for mortality of patients with acute myocardial infarction.

Joon-Myoung Kwon, Ki-Hyun Jeon, Hyue Mee Kim, Min Jeong Kim, Sungmin Lim, Kyung-Hee Kim, Pil Sang Song, Jinsik Park, Rak Kyeong Choi, Byung-Hee Oh

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04682756 (A Multicenter Study on Early Diagnosis of NSTE-ACS Patients Based on Machine Learning Model), which is not on this map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04682756 unknown statusnot on this mapstarted 2020, after this paper: background citation

A Multicenter Study on Early Diagnosis of NSTE-ACS Patients Based on Machine Learning Model

Typeobservational_patient_registrySponsorFirst Affiliated Hospital of Xinjiang Medical UniversityRan2020 to 2022Enrolled2,500ConditionsNSTEMI - Non-ST Segment Elevation MI, Unstable AnginaArmsThe model of machine learning
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joon-Myoung KwonDepartment of Emergency Medicine, Mediplex Sejong Hospital, Incheon, Korea.
Ki-Hyun JeonArtificial intelligence and big data center, Sejong medical research institute, Gyeonggi, Korea.ORCID 0000-0002-6277-7697
Hyue Mee KimDivision of Cardiology, Cardiovascular Center, Mediplex Sejong Hospital, Incheon, Korea.
Min Jeong KimDivision of Cardiology, Cardiovascular Center, Mediplex Sejong Hospital, Incheon, Korea.
Sungmin LimDivision of Cardiology, Cardiovascular Center, Mediplex Sejong Hospital, Incheon, Korea.
Kyung-Hee KimArtificial intelligence and big data center, Sejong medical research institute, Gyeonggi, Korea.
Pil Sang SongDivision of Cardiology, Cardiovascular Center, Mediplex Sejong Hospital, Incheon, Korea.
Jinsik ParkDivision of Cardiology, Cardiovascular Center, Mediplex Sejong Hospital, Incheon, Korea.
Rak Kyeong ChoiDivision of Cardiology, Cardiovascular Center, Mediplex Sejong Hospital, Incheon, Korea.
Byung-Hee OhDivision of Cardiology, Cardiovascular Center, Mediplex Sejong Hospital, Incheon, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveConventional risk stratification models for mortality of acute myocardial infarction (AMI) have potential limitations. This study aimed to develop and validate deep-learning-based risk stratification for the mortality of patients with AMI (DAMI).

methodsThe data of 22,875 AMI patients from the Korean working group of the myocardial infarction (KorMI) registry were exclusively divided into 12,152 derivation data of 36 hospitals and 10,723 validation data of 23 hospitals. The predictor variables were the initial demographic and laboratory data. The endpoints were in-hospital mortality and 12-months mortality. We compared the DAMI performance with the global registry of acute coronary event (GRACE) score, acute coronary treatment and intervention outcomes network (ACTION) score, and the thrombolysis in myocardial infarction (TIMI) score using the validation data.

resultsIn-hospital mortality for the study subjects was 4.4% and 6-month mortality after survival upon discharge was 2.2%. The areas under the receiver operating characteristic curves (AUCs) of the DAMI were 0.905 [95% confidence interval 0.902-0.909] and 0.870 [0.865-0.876] for the ST elevation myocardial infarction (STEMI) and non ST elevation myocardial infarction (NSTEMI) patients, respectively; these results significantly outperformed those of the GRACE (0.851 [0.846-0.856], 0.810 [0.803-0.819]), ACTION (0.852 [0.847-0.857], 0.806 [0.799-0.814] and TIMI score (0.781 [0.775-0.787], 0.593[0.585-0.603]). DAMI predicted 30.9% of patients more accurately than the GRACE score. As secondary outcome, during the 6-month follow-up, the high risk group, defined by the DAMI, has a significantly higher mortality rate than the low risk group (17.1% vs. 0.5%, p < 0.001).

conclusionsThe DAMI predicted in-hospital mortality and 12-month mortality of AMI patients more accurately than the existing risk scores and other machine-learning methods.

Indexed as

Acute DiseaseAgedArea Under CurveDeep LearningFemaleHospital MortalityHumansMachine LearningMaleMiddle AgedMyocardial InfarctionNon-ST Elevated Myocardial InfarctionRegistriesRepublic of KoreaRisk AssessmentRisk Factors

Identifiers

PMID31671144
PMCPMC6822714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.